Polverino Anthony J. 4
4 · Zymeworks Inc. · Filed Sep 2, 2021
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Polverino Anthony J.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Shares
2021-08-31$15.00/sh+4,900$73,500→ 36,333 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-31−4,900→ 77,600 totalExercise: $15.00Exp: 2028-12-11→ Common Shares (4,900 underlying)
Footnotes (1)
- [F1]Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of December 12, 2018, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.